354 DISEASES/DISORDERS
Atopy: intradermal testing (preferred) or serum testing followed by allergen-specific
immunotherapy.
Dermatohistopathologic diagnosis: required for definitive diagnosis and distinguish-
ing the EGC syndromes:
Eosinophilic plaque: severe epidermal and follicular spongiosis and mucinosis
with eosinophilic exocytosis; intense perivascular to diffuse dermal eosinophilic
infiltrate; eroded or ulcerated epidermis
Eosinophilic granuloma: epidermal acanthosis with scattered apoptotic ker-
atinocytes; distinct foci of eosinophilic degranulation and collagen degeneration
(“flame figures”); nodular to diffuse granulomatous inflammation; eosinophilic
and giant cell infiltrate
Indolent ulcer: severe ulceration of the epidermis or mucosa with fibrosing
dermatitis and neutrophilic inflammation; significant eosinophilic infiltration
unusual
Allergic miliary dermatitis: discrete foci of epidermal erosion and necrosis with
brightly eosinophilic crusts; dermal perivascular to interstitial eosinophil-rich
infiltrate.
CEG (dog): foci of palisading granulomas and flame figures surrounding collagen
fibers; eosinophilic infiltrate mixed with multinucleated giant cells, macrophages,
reactive mast cells, plasma cells, and lymphocytes.
THERAPEUTICS
General Considerations: Cats
Adequate flea control measures paramount to manage a majority of cases.
Outpatient unless severe oral disease prevents adequate fluid intake.
Identify and eliminate offending allergen(s) before providing medical intervention.
Allergen-specific immunotherapy in cats with atopic dermatitis; successful in a major-
ity of cases; preferable to long-term corticosteroid administration.
Deter patient from damaging lesions by excessive grooming with behavior modifica-
tion techniques and/or distraction.
General Considerations: Dogs
Individual lesions may be surgically excised or ablated via CO 2 laser if being mechan-
ically traumatized and medically unresponsive.
Drugs of Choice
Eosinophilic plaque and indolent ulcer: may improve with antibiotics: trimethoprim-
sulfadiazine 10–15 mg/kg PO BID, cephalexin 22 mg/kg PO BID, amoxicillin
trihydrate-clavulanate 12.5 mg/kg PO BID, or clindamycin 5.5 mg/kg PO BID.